NIH rejects modified plan to clone shiga toxin.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In the next few weeks, Europe's most advanced high-security pathogen lab is expected to open for business in the southern French city of Lyons, but the long-anticipated debut of this "hot" lab is not turning out to be a joyous occasion for some of those involved. Last week, the Marcel Mérieux Foundation, which paid for the lab's construction, announced that the Pasteur Institute will take over its "scientific direction" and gave Pasteur the authority to name the lab's director. The leading candidate is a Pasteur scientist, which would leave the lab's current director out in the cold.